It is manufactured in an FDA-registered, GMP-certified facility in the USA and has been independently tested for purity (99%+ HPLC verified) by third-party laboratories
This compound is not approved as a drug, diagnostic, or dietary ingredient, and is not manufactured, packaged, or marketed for consumption, self experimentation, clinical application, or any use outside properly designed and ethically approved research protocols.
In conclusion, the T-MNS eye drop had the potential to treat CNV effectively and safely in a low dosing frequency, which broke new ground for CNV theranostics
Total Ion Chromatogram & Quality Control Assessment 4
Protein misfolding and aggregation A defining feature of many NDDs is the accumulation of misfolded, aggregation-prone proteins (A and tau in AD, -synuclein in PD, SOD1/TDP-43 in ALS, etc.) [53]
Pressure will be applied to the injection site after we remove the needle